Dermabon Multi Symptom Psoriasis Control

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Dermabon Multi Symptom Psoriasis Control
Generic name
COAL TAR
Manufacturer
Dermabon de Chihuahua, S.A. de C.V.
Product type
HUMAN OTC DRUG
SPL set ID
d5b739ba-e332-41f6-9343-6ad5cc981344
SPL ID
38dece0a-453d-3502-e063-6394a90a99b0
Version
7
Effective date
2025-07-01
Source export date
2026-09-28
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:04:51
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. If condition worsens or does not improve after regular use of this product as directed, consult a doctor. Use caution when exposing skin to sunlight after applying this product, it may increase your tendency to sunburn up to 24 hours after application. Do not use for prolonged periods without consulting a doctor. do not use this proudct with other forms of psoriasis therapy, such as ultraviolet radiation or prescription drugs, unless directed to do so by a doctor. If condition covers a large area of the body, consult your doctor before using this product. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.